You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康寧傑瑞製藥(09966.HK)股東折讓12%配股 套現1.18億元
阿思達克 06-03 08:18
康寧傑瑞製藥(09966.HK)公佈,控股股東Rubymab已與獨家配售代理摩根士丹利訂立股份配售協議,配售合共1,460萬股公司現有股份,佔公司已發行股本總數(包括庫存股份)之約1.51%,每股作價8.05元,較昨日(2日)收市價9.15元折讓約12%,套現約1.18億元。 完成後,Rubymab於公司的持股量將由32.5%降至31%,續爲公司控股股東。配售事項所得款項將主要用於償還徐霆自建立業務以來積累的部分現有個人負債及債務以及其業務所得資本收益產生的相關個人稅項負債。Rubymab及徐霆均表示對公司的商業前景及長期價值保持信心。 公司預期配售事項不會對業務或營運造成任何影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account